Overview of xanomeline and trospium chloride for schizophrenia treatment, highlighting innovative approaches.
Schizophrenia is a severe mental illness associated with significant psychosocial impairment, morbidity, and mortality. There are novel, emerging interventions in the treatment of schizophrenia, and advanced practice psychiatric nurses should be familiar with innovative treatments for schizophrenia. The current article provides a brief overview of xanomeline and trospium chloride (Cobenfy™) for the treatment of schizophrenia.
No takes yet. Share an insight, caveat, or question.
Kameg et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: